MISSY EDWARDS STRATEGIES, LLC for GENENTECH
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Following issues related to the budget and appropriations process FY14 appropriations for FDA as well as the potential outcomes for negotiations on altering sequestration targets via legislation.
Foreign entity interest: F. Hoffman-LaRoche Ltd. Grenzacherstrasse 124 CH-4070 Basel SUI Basel, SUI
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA M EDWARDS | Legislative Assistant, US Senator Thad Cochran |
Health Issues HCR
S.959, "Pharmaceutical Compounding Quality and Accounting Act" H.R. 1416, "Cancer Patient Protection Act of 2013" S.957, "Drug Supply Chain Security" H.R. 1919, "Safeguarding America's Pharmaceuticals Act"
Foreign entity interest: F. Hoffman-LaRoche Ltd. Grenzacherstrasse 124 CH-4070 Basel SUI Basel, SUI
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA M EDWARDS | Legislative Assistant, US Senator Thad Cochran |
Taxation/Internal Revenue Code TAX
General tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned U.S. corporations.
Foreign entity interest: F. Hoffman-LaRoche Ltd. Grenzacherstrasse 124 CH-4070 Basel SUI Basel, SUI
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA M EDWARDS | Legislative Assistant, US Senator Thad Cochran |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.